Public Company Healthcare

Medtronic

Minneapolis, Minnesota, United States

A global healthcare technology leader providing innovations across major clinical areas through medical devices, therapies, and services.

Focus Areas
Medical devices, Therapies and services, Neurovascular portfolio

Tracked deals

5

5 tracked deals across 2021-2026.

Recent pace

3

3 tracked deals announced in the last 12 months.

Deal mix

Buyout

4 buyout · 1 divestiture

Medtronic Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Medtronic. 1 2021 1 2025 ~4 est. 3 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Medtronic plc
    Target
    SPR Therapeutics, Inc.
    Type
    Buyout

    Medtronic agreed to acquire SPR Therapeutics for approximately $650 million in cash to add SPR’s FDA-cleared Sprint (SPRINT) temporary peripheral nerve stimulation (PNS) technology to its neuromodulation/pain portfolio. Medtronic later completed the acquisition, integrating the SPRINT PNS System to expand minimally invasive, non-opioid chronic and acute pain treatment options.

  • Buyer
    Medtronic plc
    Target
    CathWorks
    Industry
    Medical Devices
    Location
    Israel
    Type
    Buyout

    Medtronic plc has completed its acquisition of CathWorks, a privately held medical device company focused on transforming how coronary artery disease is diagnosed and treated. The deal is valued at $585 million, with potential undisclosed earn-out payments, and enhances Medtronic’s interventional cardiology portfolio via the CathWorks FFRangio System.

  • Buyer
    Medtronic plc
    Target
    Scientia Vascular
    Industry
    Medical Devices
    Type
    Buyout

    Medtronic entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal, with customary adjustments and potential earn-out/milestone payments. The acquisition combines Scientia’s neurovascular access devices (guidewires and catheters) with Medtronic’s existing neurovascular therapeutic portfolio to support faster and more reliable treatment for complex stroke cases.

  • Buyer
    Medtronic plc
    Target
    Nanovis
    Seller
    Nanovis
    Industry
    Medical Devices

    Medtronic plc acquired certain nano surface technology assets and related IP rights from Columbia City, Indiana-based Nanovis to support development of next-generation PEEK interbody fusion devices. Financial terms were not disclosed; the deal transfers Nanovis’ bone-growth nanotechnology (including rights related to Sites Medical’s OsteoSync titanium pads) to Medtronic for integration into its spinal implant portfolio.

  • Buyer
    Medtronic plc
    Target
    SonarMed
    Industry
    Medical Devices
    Type
    Buyout

    Medtronic plc acquired SonarMed, a Purdue‑bred developer of the SonarMed airway monitoring system, in December 2020. The acquisition adds continuous acoustic airway monitoring technology for neonatal and pediatric ventilation to Medtronic's respiratory/medical surgical portfolio to help detect endotracheal tube obstruction and position in real time.

Related Acquisition Pages

Selling a company? Get in front of buyers like Medtronic

Turn tracked acquisition activity into an outreach-ready buyer list.